Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Re (RMAX) Cash & Equivalents (2016 - 2026)

Re has reported Cash & Equivalents over the past 14 years, most recently at $118.7 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 22.89% to $118.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $118.7 million through Dec 2025, up 22.89% year-over-year, with the annual reading at $118.7 million for FY2025, 22.89% up from the prior year.
  • Cash & Equivalents was $118.7 million for Q4 2025 at Re, up from $107.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $126.3 million in Q4 2021 and troughed at $66.1 million in Q2 2024.
  • The 5-year median for Cash & Equivalents is $99.7 million (2021), against an average of $101.1 million.
  • Year-over-year, Cash & Equivalents plummeted 31.72% in 2024 and then soared 42.76% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $126.3 million in 2021, then fell by 13.94% to $108.7 million in 2022, then decreased by 23.96% to $82.6 million in 2023, then rose by 16.94% to $96.6 million in 2024, then grew by 22.89% to $118.7 million in 2025.
  • Per Business Quant, the three most recent readings for RMAX's Cash & Equivalents are $118.7 million (Q4 2025), $107.5 million (Q3 2025), and $94.3 million (Q2 2025).